These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [The beta-adrenolytic activity of new arylmethyloxypropanolamine analogs of dioxadilol]. Baziard-Mouysset G, Ane-Margail M, Stigliani JL, Payard M, Verscheure Y, Tisne-Versailles J. J Pharm Belg; 1994 Oct; 49(2):126-32. PubMed ID: 7913492 [Abstract] [Full Text] [Related]
29. [Effect of a new beta-sympatholytic agent for ICI 66 082 on hemodynamics and cardiac contraction without and with experimental coronary occlusion]. Stephan K, Bischoff KO, Geigenmüller L, Diesch J, Meesmann W. Verh Dtsch Ges Inn Med; 1975 Oct; 81():1637-41. PubMed ID: 5832 [No Abstract] [Full Text] [Related]
30. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. Schliep HJ, Harting J. J Cardiovasc Pharmacol; 1984 Oct; 6(6):1156-60. PubMed ID: 6084774 [Abstract] [Full Text] [Related]
31. [Central effects of o-isopropylaminocyclohexylphenoxypropanol (VUL 111) (author's transl)]. Babul'ová A, Buran L, Dittertová V. Bratisl Lek Listy; 1978 Sep; 70(3):322-32. PubMed ID: 698857 [No Abstract] [Full Text] [Related]
32. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)]. Sada H, Harada S, Kojima M, Ban T. Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358 [No Abstract] [Full Text] [Related]
33. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)]. Ishihara T, Watanabe K, Takenaka F. Arzneimittelforschung; 1977 Nov; 27(11):2055-9. PubMed ID: 23789 [No Abstract] [Full Text] [Related]
34. [Contribution to the analysis of the mechanism of rebound phenomenon development following beta blockers (author's transl)]. Svec P, Béderová E, Tumová I, Inczinger F. Bratisl Lek Listy; 1979 Apr; 71(4):470-80. PubMed ID: 36211 [No Abstract] [Full Text] [Related]
35. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog]. Merlo L, Brusoni B, Minoia G, Marchetti G. Boll Soc Ital Biol Sper; 1977 Mar 30; 53(6):440-4. PubMed ID: 20906 [No Abstract] [Full Text] [Related]
37. [Effects of nitroglycerin and of the combination of nitroglycerin and beta inhibitors on systemic and coronary hemodynamics and on cardiac metabolism]. Marchetti GV, Merlo L, Brusoni B. Boll Soc Ital Cardiol; 1975 Mar 30; 20(10):1197-205. PubMed ID: 10931 [No Abstract] [Full Text] [Related]
38. Pharmacological evaluation of new alkylesters of 4-[(2-hydroxy-3-alkylamino)propoxy]phenylcarbamic acids with beta-adrenolytic properties. Racanská E, Csöllei J, Svec P. Pharmazie; 1990 Nov 30; 45(11):851-3. PubMed ID: 1983125 [Abstract] [Full Text] [Related]
39. Isoproterenol blockade in man; comparison between penbutalol and acebutolol. Coleman AJ, Leary WP, Asmal AC. Curr Ther Res Clin Exp; 1974 Jan 30; 16(1):64-79. PubMed ID: 4149207 [No Abstract] [Full Text] [Related]
40. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle. Knezl V, Magna D, Sotníková R, Drímal J. Arzneimittelforschung; 1994 Jan 30; 44(1):7-12. PubMed ID: 7907875 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]